Skip to main content

Table 2 Risks of bronchiectasis exacerbation based on baseline hs-CRP level at stable-state

From: High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk

 

Univariate logistic regression

Multivariate logistic regression#

OR

95% CI

p-value

OR

95% CI

p-value

Any bronchiectasis exacerbation

 

Hs-CRP as continuous variable

2.597

1.188–5.676

0.017*

2.365

1.042–5.364

0.039*

Hs-CRP above 0.35 mg/dL

4.222

1.700–4.885

0.002*

3.915

1.423–10.771

0.008*

Hospitalized bronchiectasis exacerbation

 

Hs-CRP as continuous variable

2.280

1.107–4.695

0.025*

2.031

0.944–4.367

0.070

Hs-CRP above 0.35 mg/dL

7.083

1.715–29.256

0.007*

4.663

1.047–20.772

0.043*

  1. #: Adjusted for smoking status, gender and E-FACED score
  2. *: p < 0.05